TickerFacts.

Mangoceuticals, Inc. (MGRX): Gross Profit

Annual figures by period end, from SEC filings.

$250.4K
Year ended 2025-12-31
$171.6K
Trailing 12 months to 2026-06-30
n/m
3-year compound annual growth
$431.5K2022-12-31: $4.8K2023-12-31: $431.5K2024-12-31: $380.0K2025-12-31: $250.4K$250.4K
2022-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$250.4K-34.1%2026-04-01, From 2025-01-01
2024-12-31$380.0K-11.9%2026-04-01, From 2024-01-01
2023-12-31$431.5Kn/m2025-03-20, From 2023-01-01
2022-12-31$4.8Kn/a2024-04-01, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Mangoceuticals, Inc. (MGRX)2025-12-31$250.4K-34.1%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$335.9K-9.9%
Cryo Cell International Inc (CCEL)2025-11-30$24.19M+0.6%
Viemed Healthcare, Inc. (VMD)2025-12-31$155.46M+16.7%
Sotera Health Co (SHC)2025-12-31$645.53M+7.2%
Progyny, Inc. (PGNY)2025-12-31$304.48M+20.2%

Compare MGRX, BRTX, CCEL, VMD side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗